Allecra Therapeutics

Business news, market intelligence, and global industry analysis.

The Latest

What the latest UTOPIA trial data reveal about UGN-103’s competitive position in LG-IR-NMIBC

Delivery Hero (DHER) stock up 4% to €29.5 as Aspex forces CEO exit and Korea sale opens

What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC

Hanwha Aerospace targets NATO demand with Romania unmanned systems push at BSDA 2026

Orchid Pharma company profile: business model, financials, and growth outlook (2026 Edition)

Orchid Pharma Limited company profile: cephalosporin API leader, FY2025 revenue Rs. 921.93 Cr, Jammu PLI expansion, novel antibiotic pipeline, and 2026-27 growth outlook.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

April 4, 2026